Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma - Concepedia

Concepedia

Publication | Open Access

Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma

DOI Full Paper Access

26

Citations

23

References

2020

Year

Didier Decaudin, Estelle Frisch Dit Leitz, Fariba Némati, Malcy Tarin, Adnan Naguez, Mohamed Zerara, Benjamin Marande, Raquel Vivet-Noguer, Ensar Halilovic, Claire Fabre,

European Journal of Cancer

References

	Year	Citations

Page 1